ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $71,869,000 | +82.7% | 773,286 | +17.1% | 0.02% | +69.2% |
| Q3 2021 | $39,331,000 | -27.3% | 660,447 | -16.8% | 0.01% | -23.5% |
| Q2 2021 | $54,122,000 | +6.5% | 793,526 | +8.3% | 0.02% | 0.0% |
| Q1 2021 | $50,830,000 | +0.6% | 732,583 | +11.4% | 0.02% | -5.6% |
| Q4 2020 | $50,504,000 | -4.9% | 657,324 | -7.4% | 0.02% | -21.7% |
| Q3 2020 | $53,100,000 | +18.6% | 709,957 | -0.2% | 0.02% | +15.0% |
| Q2 2020 | $44,774,000 | +66.4% | 711,284 | +11.0% | 0.02% | +42.9% |
| Q1 2020 | $26,911,000 | -8.9% | 640,765 | -1.5% | 0.01% | +27.3% |
| Q4 2019 | $29,538,000 | -13.4% | 650,325 | -12.7% | 0.01% | -15.4% |
| Q3 2019 | $34,115,000 | -1.4% | 745,358 | +26.4% | 0.01% | 0.0% |
| Q2 2019 | $34,585,000 | +52.4% | 589,906 | +16.6% | 0.01% | +44.4% |
| Q1 2019 | $22,689,000 | +9.8% | 506,129 | -4.6% | 0.01% | 0.0% |
| Q4 2018 | $20,663,000 | +24.9% | 530,482 | +47.5% | 0.01% | +50.0% |
| Q3 2018 | $16,542,000 | – | 359,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |